开放期刊系统

p16INK4a 及其与宫颈癌前疾病关系的研究现状

刘 旭利, 赵建 武*

摘要

细胞周期调节的失控从而导致肿瘤细胞的无限增殖,这是最终导致肿瘤发生的一大原因。抑癌基因 p16 表达的
p16INK4a 是一种 CDK4/CDK6 抑制因子,通过影响 Rb 通路进而抑制细胞 DNA 合成,在细胞周期调控中有重要意义。本
文就 P16INK4a 的结构、功能及其与宫颈癌前疾病关系做一综述。

关键词

p16INK4a;液基薄层细胞学检查;高危型人乳头瘤病毒检测;宫颈上皮内瘤变

全文:

PDF

参考

[1] World Health Organization. Global strategy to accelerate

the elimination of cervical cancer as a public health problem

[EB/OL]. [2020.11.17]. https://www.who.int/publications/i/

item/9789240014107.

[2] Serrano M, Hannon GJ, Beach D. A new regulatory motif

in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Nature. 1993 Dec 16;366(6456):704-707.

[3] Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell

cycle regulator potentially involved in genesis of many tumor

types. Science. 1994 Apr 15;264(5157):436-440.

[4] Guo T, Chai X, Liu Q, et al. Downregulation of P16

promotes cigarette smoke extract-induced vascular smooth muscle

cell proliferation via preventing G1/S phase transition. Exp Ther

Med. 2017 Jul;14(1):214-220.

[5] Tam SW, Shay JW, Pagano M. Differential expression and

cell cycle regulation of the cyclin-dependent kinase 4 inhibitor

p16Ink4. Cancer Res. 1994 Nov 15;54(22):5816-5820.

[6] 兰晓卉 , 杨琦 , 邹颖刚 , 等 . p16INK4a 免疫细胞化学

染色对不同基因型 HPV 感染者的分流价值 [J]. 吉林大学 学

报(医学版),2021,47(2):421-429.

[7] Koliopoulos G, Nyaga VN, Santesso N, et al. Cytology

versus HPV testing for cervical cancer screening in the

general population. Cochrane Database Syst Rev. 2017 Aug

10;8(8):CD008587.

[8] Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a)

immunostaining in cytological and histological specimens from

the uterine cervix: a systematic review and meta-analysis. Cancer

Treat Rev. 2009 May;35(3):210-220.

[9] 叶洪楠 , 游珂 , 郭艳利 , 等 . P16INK4a 及 Ki-67 免疫

细胞化学检测对 ASC-US 中高级别病变检出的意义 [J]. 肿瘤

预防与治疗 ,2014,27(1):6-11.

[10] Gustafsson L, Adami HO. Natural history of cervical

neoplasia: consistent results obtained by an identification

technique. Br J Cancer. 1989 Jul;60(1):132-141.

[11] Zuberi Z, Mremi A, Chilongola JO, et al. Expression

analysis of p16 and TOP2A protein biomarkers in cervical cancer

lesions and their correlation with clinico-histopathological

characteristics in a referral hospital, Tanzania. PLoS One. 2021

Oct 27;16(10): e0259096.

[12] Zhao F, Ma D, Wang T, et al. The Application of Liquid-

Based Cytological Detection for P16, Cytologic Evaluation and

High-Risk Human Papillomavirus Testing in Cervical Cancer

Screening: A Clinical Evaluation. Int J Womens Health. 2022 Jul

28; 14:965-973.

[13] Wright Thomas C, Stoler Mark H, Ferenczy

Alex, et al. The CERTAIN Study Results: Adjunctive p16

Immunohistochemistry Use in Cervical Biopsies According

to LAST Criteria. The American journal of surgical

pathology,2021,45(10).

[14] 黄丽萍 , 林霞 .P16 蛋白表达在分流宫颈上皮内瘤变

Ⅱ中的临床意义 [J]. 中国医药导报 ,2018,15(02):83-86.

[15] 刘静云 , 吕志红 , 徐芳 , 等 . 微管蛋白及 P16 蛋白在

宫颈上皮内瘤变Ⅱ~Ⅲ级患者宫颈环形电切术后复发预测

模型的应用分析 . 中国医学装备 ,2022,19(6):101-105.


(2 摘要 Views, 1 PDF Downloads)

Refbacks

  • 当前没有refback。